Catalogue: Drug target reagents
Posted: 20 April 2021 | Sino Biological Inc. | No comments yet
5,000+ drug target reagents for antibody, small molecule drug discovery and development, including immune checkpoints, cytokines and kinases.
To support basic research, translational research, and drug development, Sino Biological has developed a panel of reagents supporting multiple therapeutic areas, including oncology, respiratory diseases, autoimmune diseases, and infective diseases.
Related content from this organisation
- Sino Biological announces construction of its new US-Based centre for bioprocessing
- Application note: Afucosylated mAb expression & antibody efficacy
- Whitepaper: Recombinant protein expression using a BEVS
- Sino Biological and Ainnocence partner to offer next-generation antibody development CRO services
- Sino Biological invests over 200M RMB to establish new subsidiaries in Taizhou and Suzhou, China
Related topics
Antibodies, Biomarkers, Biopharmaceuticals, Cytokines, Disease Research, Drug Development, Drug Discovery, Drug Targets, Hit-to-Lead, Immunology, Kinases, Proteomics, Screening, Sequencing, Small molecule, Toxicology
Related organisations
Sino Biological Inc.
